Abstract

Peritoneal dialysis (PD) is a more continuous alternative to haemodialysis, for patients with chronic kidney disease, with considerable initial benefits for survival, patient independence and healthcare costs. However, long-term PD is associated with significant pathology, negating the positive effects over haemodialysis. Importantly, peritonitis and activation of macrophages is closely associated with disease progression and treatment failure. However, recent advances in macrophage biology suggest opposite functions for macrophages of different cellular origins. While monocyte-derived macrophages promote disease progression in some models of fibrosis, tissue resident macrophages have rather been associated with protective roles. Thus, we aimed to identify the relative contribution of tissue resident macrophages to PD induced inflammation in mice. Unexpectedly, we found an incremental loss of homeostatic characteristics, anti-inflammatory and efferocytic functionality in peritoneal resident macrophages, accompanied by enhanced inflammatory responses to external stimuli. Moreover, presence of glucose degradation products within the dialysis fluid led to markedly enhanced inflammation and almost complete disappearance of tissue resident cells. Thus, alterations in tissue resident macrophages may render long-term PD patients sensitive to developing peritonitis and consequently fibrosis/sclerosis.

Highlights

  • An estimated 5-10 million people worldwide die every year due to chronic kidney disease [1]

  • Treatment failure is commonly associated with repeated episodes of peritonitis and a progressive thickening and vascularisation of the peritoneum, leading to impaired filtration and reduced efficacy of Peritoneal dialysis (PD) [6, 7]

  • To determine the impact of peritoneal dialysis fluid (PD fluid) injection on peritoneal MF populations we first characterised the cellular dynamics induced after a single application of PD fluid

Read more

Summary

Introduction

An estimated 5-10 million people worldwide die every year due to chronic kidney disease [1]. In Europe, an average of 850 people per million population (pmp) require renal replacement therapy (RRT) and 120 new patients pmp commence treatment annually [2]. The average 5-year survival rate of patients receiving RRT is only 50.5%. This can be improved to over 90% if patients receive a kidney transplant, but rates of transplantation remain low (32 pmp) primarily due to organ availability, and the majority of patients rely on dialysis as a therapy to substitute excretory kidney function [2]. The fibrotic changes to the peritoneum become so extreme that they form a fibrous cocoon encapsulating the internal organs, called Encapsulating Peritoneal Sclerosis (EPS), leading to persistent or recurring adhesive bowel obstruction [7,8,9]. Experimental rodent models of the disease, have suggested inappropriate or excessive activation of macrophages (MF) as a major cause of the pathology [11,12,13,14]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call